Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions

6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions

US Patent 7820670 · Granted Oct 26, 2010

Estimated economic value: $105,041,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleotide derivatives and methods of use thereof2025
Tris-substituted biguanide compounds and their uses2024
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2024
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2024
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2024
Nucleotide derivatives and methods of use thereof2022
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2021
Branched polymeric biguanide compounds and their uses2021
NPR-B agonists2018
Methods of treating ophthalmic diseases using NPR-B agonists2017
NPR-B agonists2017
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators2017